Medtronic, a global medical technology company headquartered in Galway, Ireland, has signed an agreement to acquire Scientia Vascular, a Salt Lake City company developing technology across the neurovascular medical field.
The acquisition is valued at $550 million, subject to post-acquisition adjustments and milestone payments.
Scientia is a private company with approximately 310 employees. Under its founder and current chief technology officer, John Lippert, the company has developed products that enable simplicity and access for physicians treating complex neurovascular conditions. Scientia’s portfolio of guidewires and catheters will be integrated with Medtronic’s existing suite of neurovascular products, strengthening the company’s ability to support physicians across the full procedural workflow, the firm said in its announcement.
“Medtronic is thrilled to acquire Scientia to accelerate meaningful innovation in neurovascular care,” said Linnea Burman, senior vice president and president of Medtronic’s neurovascular business unit, which is part of its neuroscience portfolio. “This acquisition positions Medtronic with a full suite of products. It builds a strong foundation for Medtronic and supports procedures across both hemorrhagic and acute ischemic stroke. Medtronic’s best-in-class therapies, combined with Scientia’s leading access portfolio, will be incredibly powerful. With 12 million people globally suffering from stroke each year, we look forward to contributing to better patient outcomes around
the world.”
“As a company committed to improving patients’ lives, we are humbled and excited for what’s ahead,” said Rick Randall, CEO of Scientia. “Scientia has developed critical technology that has been embraced by physicians. This deal allows us to take our engineering into disease states globally and positions Medtronic with a comprehensive portfolio and complete guidewire line. With the size and scale of Medtronic, the opportunity to treat more patients and drive more impact is truly exciting.”
This acquisition is expected to close in the first half of fiscal year 2027.